Christina Farr is the editor-in-chief/CEO of Second Opinion, and a GP at early-stage healthcare fund Scrub Capital.
Proven strategies to actually show up
A year-ahead roundup on health plan M&A, autonomous care, CMS ACCESS, rising costs, and where innovation is actually heading.
CMS unveils a new program - Elevate - to test lifestyle interventions
Lessons from the field from Premier’s Kaycee Kalpin
Real, unfiltered interviews with the leaders who refuse to quit on healthcare.
We explore CMS’ new payment model for expanding access to care with technology.
This week’s news and headlines unpacked, plus a Q&A with Jacquelyn Miller
RCM is about to hit its fourth - and potentially final phase
From GLP-1 pricing to cash-pay care, the system is shifting toward a leaner, consumer-driven future — one that rewards those who rethink what insurance is for.
This week’s news and headlines unpacked, plus a Q&A with Rushika Fernandopulle
5 principles for patient-facing AI, according to top clinicians
It’s not a good moment to be a health insurer - unless you’re Cigna (at least for now)
A recently-published analysis shows that provider pricing in the commercial market is essentially random, and there’s no correlation to quality
Practical solutions are coming and we explore 9 of them
More physicians go all-state, spending tilts to digital, and Four Questions with Jessie Beegle on the AI architecture and integrations that matter.
Every clinician in digital health should be familiar with these.”
Plus, magnesium for hormones and 7k steps for longevity.Post
As Americans juggle cash-pay care and high-deductible insurance, companies like Aidoc, Datavant, and Prosper AI are testing whether tech can ease the pressure.
Plus, a review of Prenuvo’s enhanced screening
As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness - and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!
Why “Power Law” venture math is more challenging for value-based care, versus fee-for-service, and whether AI will make a difference